1
|
Zhang Q, Zhao Y, Wu J, Zhong W, Huang W, Pan Y. The progress of small molecules against cannabinoid 2 receptor (CB 2R). Bioorg Chem 2024; 144:107075. [PMID: 38218067 DOI: 10.1016/j.bioorg.2023.107075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2023] [Revised: 12/03/2023] [Accepted: 12/27/2023] [Indexed: 01/15/2024]
Abstract
The two subtypes of cannabinoid receptors (CBR), namely CB1R and CB2R, belong to the G protein-coupled receptor (GPCR) superfamily and are confirmed as potential therapeutic targets for a variety of diseases such as inflammation, neuropathic pain, and immune-related disorders. Since CB1R is mainly distributed in the central nervous system (CNS), it could produce severe psychiatric adverse reactions and addiction. In contrast, CB2R are predominantly distributed in the peripheral immune system with minimal CNS-related side effects. Therefore, more attention has been devoted to the discovery of CB2R ligands. In view of the favorable profile of CB2R, many high-binding affinity and selectivity CB2R ligands have been developed recently. This paper reviews recent research progress on CB2R ligands, including endogenous CB2R ligands, natural compounds, and novel small molecules, in order to provide a reference for subsequent CB2R ligand development.
Collapse
Affiliation(s)
| | - Ying Zhao
- Hangzhou Medical College, Hangzhou, Zhejiang, China
| | - Jianan Wu
- Hangzhou Medical College, Hangzhou, Zhejiang, China
| | | | - Wenhai Huang
- Hangzhou Medical College, Hangzhou, Zhejiang, China.
| | - Youlu Pan
- Hangzhou Medical College, Hangzhou, Zhejiang, China.
| |
Collapse
|
2
|
Ghalloo BA, Khan KUR, Ahmad S, Aati HY, Al-Qahtani JH, Ali B, Mukhtar I, Hussain M, Shahzad MN, Ahmed I. Phytochemical Profiling, In Vitro Biological Activities, and In Silico Molecular Docking Studies of Dracaena reflexa. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27030913. [PMID: 35164177 PMCID: PMC8838819 DOI: 10.3390/molecules27030913] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/19/2022] [Accepted: 01/25/2022] [Indexed: 01/07/2023]
Abstract
Dracaena reflexa, a traditionally significant medicinal plant, has not been extensively explored before for its phytochemical and biological potential. The present study was conducted to evaluate the bioactive phytochemicals and in vitro biological activities of D. reflexa, and perform in silico molecular docking validation of D. reflexa. The bioactive phytochemicals were assessed by preliminary phytochemical testing, total bioactive contents, and GC-MS analysis. For biological evaluation, the antioxidant (DPPH, ABTS, CUPRAC, and ABTS), antibacterial, thrombolytic, and enzyme inhibition (tyrosinase and cholinesterase enzymes) potential were determined. The highest level of total phenolic contents (92.72 ± 0.79 mg GAE/g extract) was found in the n-butanol fraction while the maximum total flavonoid content (110 ± 0.83 mg QE/g extract) was observed in methanolic extract. The results showed that n-butanol fraction exhibited very significant tyrosinase inhibition activity (73.46 ± 0.80) and acetylcholinesterase inhibition activity (64.06 ± 2.65%) as compared to other fractions and comparable to the standard compounds (kojic acid and galantamine). The methanolic extract was considered to have moderate butyrylcholinesterase inhibition activity (50.97 ± 063) as compared to the standard compound galantamine (53.671 ± 0.97%). The GC-MS analysis of the n-hexane fraction resulted in the tentative identification of 120 bioactive phytochemicals. Furthermore, the major compounds as identified by GC-MS were analyzed using in silico molecular docking studies to determine the binding affinity between the ligands and the enzymes (tyrosinase, acetylcholinesterase, and butyrylcholinesterase enzymes). The results of this study suggest that Dracaena reflexa has unquestionable pharmaceutical importance and it should be further explored for the isolation of secondary metabolites that can be employed for the treatment of different diseases.
Collapse
Affiliation(s)
- Bilal Ahmad Ghalloo
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; (B.A.G.); (S.A.); (M.N.S.); (I.A.)
| | - Kashif-ur-Rehman Khan
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; (B.A.G.); (S.A.); (M.N.S.); (I.A.)
- Correspondence: (K.-u.-R.K.); (H.Y.A.); Tel.: 92-3366708638 (K.-u.-R.K.)
| | - Saeed Ahmad
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; (B.A.G.); (S.A.); (M.N.S.); (I.A.)
| | - Hanan Y. Aati
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia;
- Correspondence: (K.-u.-R.K.); (H.Y.A.); Tel.: 92-3366708638 (K.-u.-R.K.)
| | - Jawaher H. Al-Qahtani
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia;
| | - Barkat Ali
- National Agri Research Institute-NARC, Park Road Chack Shahzad Islamabad, Islamabad 45600, Pakistan;
| | - Imran Mukhtar
- Faculty of Medicine & Allied Health Sciences, Sir Sadiq Muhammad Khan Abbasi Post Graduate Medical College, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan;
| | - Musaddique Hussain
- Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan;
| | - Muhammad Nadeem Shahzad
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; (B.A.G.); (S.A.); (M.N.S.); (I.A.)
| | - Imtiaz Ahmed
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; (B.A.G.); (S.A.); (M.N.S.); (I.A.)
| |
Collapse
|
3
|
Páez JA, Campillo NE. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases. Curr Med Chem 2019; 26:3300-3340. [DOI: 10.2174/0929867325666180226095132] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2017] [Revised: 02/08/2018] [Accepted: 02/15/2018] [Indexed: 02/07/2023]
Abstract
:
The discovery of cannabinoid receptors at the beginning of the 1990s, CB1 cloned
in 1990 and CB2 cloned in 1993, and the availability of selective and potent cannabimimetics
could only be justified by the existence of endogenous ligands that are capable of binding to
them. Thus, the characterisation and cloning of the first cannabinoid receptor (CB1) led to the
isolation and characterisation of the first endocannabinoid, arachidonoylethanolamide (AEA),
two years later and the subsequent identification of a family of lipid transmitters known as the
fatty acid ester 2-arachidonoylglycerol (2-AG).
:
The endogenous cannabinoid system is a complex signalling system that comprises transmembrane
endocannabinoid receptors, their endogenous ligands (the endocannabinoids), the
specific uptake mechanisms and the enzymatic systems related to their biosynthesis and degradation.
:
The endocannabinoid system has been implicated in a wide diversity of biological processes,
in both the central and peripheral nervous systems, including memory, learning, neuronal development,
stress and emotions, food intake, energy regulation, peripheral metabolism, and
the regulation of hormonal balance through the endocrine system.
:
In this context, this article will review the current knowledge of the therapeutic potential of
cannabinoid receptor as a target in Alzheimer’s disease and other less well-known diseases
that include, among others, multiple sclerosis, bone metabolism, and Fragile X syndrome.
:
The therapeutic applications will be addressed through the study of cannabinoid agonists acting
as single drugs and multi-target drugs highlighting the CB2 receptor agonist.
Collapse
Affiliation(s)
- Juan A. Páez
- Instituto de Quimica Medica (IQM-CSIC). C/ Juan de la Cierva, 3, 28006, Madrid, Spain
| | - Nuria E. Campillo
- Centro de Investigaciones Biologicas (CIB-CSIC). C/ Ramiro de Maeztu, 9, 28040, Madrid, Spain
| |
Collapse
|
4
|
Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies. Eur J Med Chem 2017. [DOI: 10.1016/j.ejmech.2017.05.060] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
5
|
Turcotte C, Blanchet MR, Laviolette M, Flamand N. The CB 2 receptor and its role as a regulator of inflammation. Cell Mol Life Sci 2016; 73:4449-4470. [PMID: 27402121 PMCID: PMC5075023 DOI: 10.1007/s00018-016-2300-4] [Citation(s) in RCA: 344] [Impact Index Per Article: 43.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Revised: 06/20/2016] [Accepted: 06/27/2016] [Indexed: 12/12/2022]
Abstract
The CB2 receptor is the peripheral receptor for cannabinoids. It is mainly expressed in immune tissues, highlighting the possibility that the endocannabinoid system has an immunomodulatory role. In this respect, the CB2 receptor was shown to modulate immune cell functions, both in cellulo and in animal models of inflammatory diseases. In this regard, numerous studies have reported that mice lacking the CB2 receptor have an exacerbated inflammatory phenotype. This suggests that therapeutic strategies aiming at modulating CB2 signaling could be promising for the treatment of various inflammatory conditions. Herein, we review the pharmacology of the CB2 receptor, its expression pattern, and the signaling pathways induced by its activation. We next examine the regulation of immune cell functions by the CB2 receptor and the evidence obtained from primary human cells, immortalized cell lines, and animal models of inflammation. Finally, we discuss the possible therapies targeting the CB2 receptor and the questions that remain to be addressed to determine whether this receptor could be a potential target to treat inflammatory disease.
Collapse
Affiliation(s)
- Caroline Turcotte
- Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Département de médecine, Faculté de médecine, Université Laval, Quebec, QC, G1V 4G5, Canada
| | - Marie-Renée Blanchet
- Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Département de médecine, Faculté de médecine, Université Laval, Quebec, QC, G1V 4G5, Canada
| | - Michel Laviolette
- Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Département de médecine, Faculté de médecine, Université Laval, Quebec, QC, G1V 4G5, Canada
| | - Nicolas Flamand
- Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Département de médecine, Faculté de médecine, Université Laval, Quebec, QC, G1V 4G5, Canada.
| |
Collapse
|
6
|
Aghazadeh Tabrizi M, Baraldi PG, Borea PA, Varani K. Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists. Chem Rev 2016; 116:519-60. [PMID: 26741146 DOI: 10.1021/acs.chemrev.5b00411] [Citation(s) in RCA: 80] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Mojgan Aghazadeh Tabrizi
- Department of Chemical and Pharmaceutical Sciences and ‡Department of Medical Science, Pharmacology Section, University of Ferrara , Ferrara 44121, Italy
| | - Pier Giovanni Baraldi
- Department of Chemical and Pharmaceutical Sciences and ‡Department of Medical Science, Pharmacology Section, University of Ferrara , Ferrara 44121, Italy
| | - Pier Andrea Borea
- Department of Chemical and Pharmaceutical Sciences and ‡Department of Medical Science, Pharmacology Section, University of Ferrara , Ferrara 44121, Italy
| | - Katia Varani
- Department of Chemical and Pharmaceutical Sciences and ‡Department of Medical Science, Pharmacology Section, University of Ferrara , Ferrara 44121, Italy
| |
Collapse
|
7
|
Jadhav GR, Deshmukh DG, Medhane VJ, Gaikwad VB, Bholay AD. 2,5-Disubstituted 1,3,4-oxadiazole derivatives of chromeno[4,3-b]pyridine: synthesis and study of antimicrobial potency. HETEROCYCL COMMUN 2016. [DOI: 10.1515/hc-2015-0215] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
AbstractA convenient synthesis of 1,3,4-oxadiazole containing derivatives of chromeno[4,3-
Collapse
|
8
|
Baral ER, Sharma K, Akhtar MS, Lee YR. A catalyst- and solvent-free thermal multicomponent approach for the construction of diverse and polysubstituted 2-aminopyridines and their antibacterial activity. Org Biomol Chem 2016; 14:10285-10297. [PMID: 27752699 DOI: 10.1039/c6ob02015a] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
A multicomponent approach for the synthesis of polysubstituted 2-aminopyridines under catalyst- and solvent-free thermal conditions has been established.
Collapse
Affiliation(s)
- Ek Raj Baral
- School of Chemical Engineering
- Yeungnam University
- Gyeongsan 712-749
- Republic of Korea
| | - Kavita Sharma
- School of Chemical Engineering
- Yeungnam University
- Gyeongsan 712-749
- Republic of Korea
| | | | - Yong Rok Lee
- School of Chemical Engineering
- Yeungnam University
- Gyeongsan 712-749
- Republic of Korea
| |
Collapse
|
9
|
Manna S, Serebrennikova PO, Utepova IA, Antonchick AP, Chupakhin ON. Hypervalent Iodine(III) in Direct Oxidative Amination of Arenes with Heteroaromatic Amines. Org Lett 2015; 17:4588-91. [DOI: 10.1021/acs.orglett.5b02320] [Citation(s) in RCA: 82] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- Srimanta Manna
- Chemische
Biologie, Max-Planck-Institut für Molekulare Physiologie, Otto-Hahn-Straße 11, 44227 Dortmund, Germany
- Fakultät
Chemie und Chemische Biologie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227 Dortmund, Germany
| | - Polina O. Serebrennikova
- Chemische
Biologie, Max-Planck-Institut für Molekulare Physiologie, Otto-Hahn-Straße 11, 44227 Dortmund, Germany
- Ural Federal University, 19 Mira Straße, 620002 Ekaterinburg, Russian Federation
| | - Irina A. Utepova
- Ural Federal University, 19 Mira Straße, 620002 Ekaterinburg, Russian Federation
| | - Andrey P. Antonchick
- Chemische
Biologie, Max-Planck-Institut für Molekulare Physiologie, Otto-Hahn-Straße 11, 44227 Dortmund, Germany
- Fakultät
Chemie und Chemische Biologie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227 Dortmund, Germany
| | - Oleg N. Chupakhin
- Ural Federal University, 19 Mira Straße, 620002 Ekaterinburg, Russian Federation
| |
Collapse
|
10
|
Cichero E, Menozzi G, Guariento S, Fossa P. Ligand-based homology modelling of the human CB2 receptor SR144528 antagonist binding site: a computational approach to explore the 1,5-diaryl pyrazole scaffold. MEDCHEMCOMM 2015. [DOI: 10.1039/c5md00333d] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
SR144528 docking mode into the LBHM of the human CB2 receptor antagonist binding site.
Collapse
Affiliation(s)
- Elena Cichero
- Department of Pharmacy
- University of Genoa
- 3 - 16132 Genoa
- Italy
| | - Giulia Menozzi
- Department of Pharmacy
- University of Genoa
- 3 - 16132 Genoa
- Italy
| | - Sara Guariento
- Department of Pharmacy
- University of Genoa
- 3 - 16132 Genoa
- Italy
| | - Paola Fossa
- Department of Pharmacy
- University of Genoa
- 3 - 16132 Genoa
- Italy
| |
Collapse
|
11
|
Han S, Thatte J, Buzard DJ, Jones RM. Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists. J Med Chem 2013; 56:8224-56. [DOI: 10.1021/jm4005626] [Citation(s) in RCA: 100] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Sangdon Han
- Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San
Diego, California 92121, United States
| | - Jayant Thatte
- Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San
Diego, California 92121, United States
| | - Daniel J. Buzard
- Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San
Diego, California 92121, United States
| | - Robert M. Jones
- Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San
Diego, California 92121, United States
| |
Collapse
|
12
|
LaPlante SR, Bilodeau F, Aubry N, Gillard JR, O'Meara J, Coulombe R. N- versus O-alkylation: utilizing NMR methods to establish reliable primary structure determinations for drug discovery. Bioorg Med Chem Lett 2013; 23:4663-8. [PMID: 23809849 DOI: 10.1016/j.bmcl.2013.06.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2013] [Revised: 05/23/2013] [Accepted: 06/03/2013] [Indexed: 01/13/2023]
Abstract
A classic synthetic issue that remains unresolved is the reaction that involves the control of N- versus O-alkylation of ambident anions. This common chemical transformation is important for medicinal chemists, who require predictable and reliable protocols for the rapid synthesis of inhibitors. The uncertainty of whether the product(s) are N- and/or O-alkylated is common and can be costly if undetermined. Herein, we report an NMR-based strategy that focuses on distinguishing inhibitors and intermediates that are N- or O-alkylated. The NMR strategy involves three independent and complementary methods. However, any combination of two of the methods can be reliable if the third were compromised due to resonance overlap or other issues. The timely nature of these methods (HSQC/HMQC, HMBC. ROESY, and (13)C shift predictions) allows for contemporaneous determination of regioselective alkylation as needed during the optimization of synthetic routes.
Collapse
Affiliation(s)
- Steven R LaPlante
- Department of Chemistry, Boehringer Ingelheim (Canada) Ltd, 2100 Cunard St., Laval, Quebec H7S 2G5, Canada.
| | | | | | | | | | | |
Collapse
|
13
|
New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation. Eur J Med Chem 2013; 62:677-87. [PMID: 23434641 DOI: 10.1016/j.ejmech.2012.12.055] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Revised: 12/13/2012] [Accepted: 12/23/2012] [Indexed: 01/21/2023]
Abstract
A novel series of 5-(2-benzylsulfanyl-pyridin-3-yl)-2-(substituted)-sulfanyl-1,3,4-oxadiazoles 6a-j were synthesized from key intermediate 5-(2-benzylsulfanyl-pyridin-3-yl)-3H-[1,3,4]oxadiazole-2-thione 5. Nucleophilic substitution reactions with different electrophiles (E+), such as haloacetate and haloalkyl groups, were performed to get target compounds 6a-j. Compounds were characterized by NMR, mass, IR spectra and C, H, N analyses. All compounds were evaluated for their antimicrobial and antimycobacterial activities; selected analogs were screened for their anticancer activity on 60 tumor cell lines at single dose 1.00(-5) M. Unfortunately, none of the compounds showed a significant antitumor activity on 60 human tumor cell lines. However, compounds 6g and 6f with benzothiazole moiety (12.5 and 25 μg/ml) showed promising activity against Escherichia coli compared to ampicillin; compounds 6d, 6j bearing triazole and morpholine, respectively, showed promising antitubercular activity (25 μg/ml) compared to rifampicin.
Collapse
|
14
|
Dyachenko VD, Bityukova OS. Synthesis and structure of 2-amino-1-benzyl-4-methylthio-6-oxo-N-phenyl-5-cyano-1,6-dihydropyridin-3-ylcarboxamide. RUSS J GEN CHEM+ 2012. [DOI: 10.1134/s1070363212030164] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
15
|
Dyachenko VD, Bityukova OS, Dyachenko AD, Shishkin OV. Competing processes in condensation of 3,3-bis(methylthio)-2-cyano-N-arylacrylamides with cyanoacetanilides. RUSS J GEN CHEM+ 2011. [DOI: 10.1134/s1070363211050185] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
16
|
Akkurt M, Celik I, Demir H, Ozkırımlı S, Büyükgüngör O. N-[2-(4-Chloro-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide. Acta Crystallogr Sect E Struct Rep Online 2011; 67:o745-6. [PMID: 21754043 PMCID: PMC3099898 DOI: 10.1107/s1600536811007136] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2011] [Accepted: 02/24/2011] [Indexed: 11/18/2022]
Abstract
The title compound, C16H14ClN3O2S, crystallizes with two molecules in the asymmetric unit. In the 1,3-thiazolidine rings, the carbonyl O atoms, the S atoms, the methyl groups and the ring carbon attached to the methyl groups are disordered with occupancy ratios of 0.509 (7):0.491 (7) in one molecule and 0.464 (14):0.536 (14) in the other. The crystal structure is stabilized by intermolecular N—H⋯N, C—H⋯O hydrogen bonds and C—H⋯Cl interactions. In addition, there is a π–π stacking interaction [centroid–centroid distance = 3.794 (3) Å] between the benzene and pyridine rings.
Collapse
|
17
|
Troegel D, Möller F, Tacke R. (2-Halogeno-5-pyridyl)dimethyl(oxiran-2-ylmethyl)silanes: New potential building blocks for the synthesis of silicon-containing drugs. J Organomet Chem 2010. [DOI: 10.1016/j.jorganchem.2009.10.020] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
18
|
Giblin GMP, Billinton A, Briggs M, Brown AJ, Chessell IP, Clayton NM, Eatherton AJ, Goldsmith P, Haslam C, Johnson MR, Mitchell WL, Naylor A, Perboni A, Slingsby BP, Wilson AW. Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain. J Med Chem 2009; 52:5785-8. [PMID: 19743867 DOI: 10.1021/jm9009857] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We report the synthesis and SAR of a series of novel azaindole CB(2) agonists. 6-Azaindole 18 showed activity in an acute pain model but was inactive in a chronic model. 18 is a Pgp substrate with low brain penetration. The template was redesigned, and the resulting 5-azaindole 36 was a potent CB(2) agonist with high CNS penetration. This compound was efficacious in the acute model and the chronic joint pain model.
Collapse
Affiliation(s)
- Gerard M P Giblin
- Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Chapter 11 Recent Advances in the Discovery of CB2 Selective Agonists. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 2009. [DOI: 10.1016/s0065-7743(09)04411-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register]
|